Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132801) titled 'Comparison of Two Qualia NAD? Formulations on Intracellular NAD? Levels' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Qualia Life Sciences
Condition:
NAD
NAD+ Levels in the Blood
Intervention:
Dietary Supplement: Qualia NAD? version 2
Dietary Supplement: Qualia NAD? version 1
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 13, 2025
Target Sample Size: 180
Countries of Recruitment:
United States
...